A 60-year-old Danish woman who received the AstraZeneca COVID-19 vaccine reportedly had ‘extremely unusual symptoms’ before she died of a blood clot.
The woman had a low number of platelets and blood clots in small and large vessels, Reuters reported, citing the Danish Medicines Agency.
The agency cited a number of similar cases reported in Norway and in the European Medicines Agency’s database of side effects, according to the news agency.
“It was an unusual course of illness surrounding the death that caused the Danish Medicines Agency to respond,” it said in a statement on Sunday night.
On Saturday, Norway said three people – all under the age of 50 – who got the jab were being treated in a hospital for bleeding, blood clots and a low platelet count, which health officials described as “unusual symptoms”.
Denmark, Norway and Iceland said last week that they would stop the launch of the AstraZeneca shot.
European vaccination programs have been shocked by recent reports that recipients of the AstraZeneca vaccination have contracted blood clots.
The European Medicines Agency said there was no indication that the cases were related to the vaccination, an opinion reflected by the World Health Organization on Friday.
AstraZeneca tried to alleviate safety issues after blood clots developed in some people, leading to a dozen countries to stop using some or all of their doses.
The UK drugmaker’s review of safety data from more than 17 million people who received the shot in the UK and the European Union found no evidence of a higher risk of pulmonary embolism or deep vein thrombosis. .
According to AstraZeneca, there were also no signs of a higher risk of thrombocytopenia, a low platelet count.